• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 431012 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1418942963 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1418942963 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Possible Bearish Inside Day Candle Pattern Detected for Salix Pharmaceuticals (NASDAQ:SLXP)

Published on Tue, 01/29/2013 - 08:29
By Adrienne Chilton

Analysts have spotted a possible bearish inside day candle pattern in Salix Pharmaceuticals (NASDAQ:SLXP) based on the price action in the company's shares. Yesterday's price range of $46.64 and $47.68 is within the prior day's high and low of the day. This trading action often signifies indecision by bulls and bears to drive prices higher or lower and often implies a possible change in trend. Owners of Salix Pharmaceuticals may want to consider a possible hedge in the event a pullback occurs. Look for confirmation in the next few trading days.

Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. The Company's COLAZAL product is an anti-inflammatory drug used for the treatment of mildly to moderately active ulcerative colitis.

Salix Pharmaceuticals (NASDAQ:SLXP) has potential upside of 11.2% based on a current price of $46.92 and analysts' consensus price target of $52.17. The stock should discover initial support at its 200-day moving average (MA) of $46.00 and subsequent support at its 50-day MA of $42.91.

In the past 52 weeks, Salix Pharmaceuticals share prices have been bracketed by a low of $37.52 and a high of $55.99 and closed yesterday at $46.92, 25% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.9% while the 200-day MA has remained constant.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Shares of Western Digital Rise Above Pre...

Shares of Western Digital (NYSE:WDC) traded today at $112.21, breaking its 52-week high ...

WellCare Health Plans: The Winning Strea...

Shares of WellCare Health Plans (NYSE:WCG) traded at a new 52-week high today of $79.34 ...

Shares of Vornado Realty Trust Rise Abov...

Shares of Vornado Realty Trust (NYSE:VNO) traded at a new 52-week high today of $115.96 ...

Watch for Continued Losses in Shares of ...

Shares of UQM Technologies (AMEX:UQM) traded at a new 52-week low today of $0.85. Appr ...

Universal Electronics Looks to Continue ...

Shares of Universal Electronics (NASDAQ:UEIC) traded today at $63.71, breaking its 52-w ...

Shares of United Community Financial Ris...

Shares of United Community Financial (NASDAQ:UCFC) traded today at $5.50, breaking its ...

TriQuint Semiconductor Looks to Continue...

TriQuint Semiconductor (NASDAQ:TQNT) traded at a new 52-week high today of $26.84. Thi ...

Shares of Target Have Risen Above Previo...

Target (NYSE:TGT) traded at a new 52-week high today of $74.87. So far today approxima ...